News
Successful results in subcutaneous repeated dose study in rats
TIRmed successfully completes key toxicity study
July 4, 2024
TIRmed successfully completes key toxicity study
July 4, 2024
In a recent development, TIRmed has conducted a biodistribution study that has yielded very promising results. The study, focused on dermal applications, marks a significant milestone in the company's ongoing research efforts.
July 4, 2024
TIRmed Pharma is pleased to announce the appointment of Pirkko Tamsen as a new member of its Board of Directors.
July 4, 2024
We're excited to introduce our two new interns, Amirreza and Jianjian, who have been driving a market intelligence research project this spring.
July 4, 2024